Outcomes Associated With Norepinephrine Use Among Cardiac Intensive Care Unit Patients with Severe Shock
- 3 March 2021
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Shock
- Vol. 56 (4), 522-528
- https://doi.org/10.1097/shk.0000000000001767
Abstract
Background: Recent data suggests improved outcomes among cardiac intensive care unit (CICU) patients treated with norepinephrine, especially patients with severe shock. We aimed to describe the association between norepinephrine and mortality in CICU patients with severe shock, defined as those requiring high dose vasopressors (HDV). Materials and Results: We retrospectively evaluated Mayo Clinic CICU patients treated with vasopressors from 2007 to 2015. HDV was defined as a peak Cumulative Vasopressor Index of 4 for any vasopressor. Peak norepinephrine equivalent (NEE) dose was used to compare vasopressor doses. Multivariable logistic regression was used to determine predictors of hospital mortality. Results: We included 2,090 patients with a median age of 69 years (IQR 59–78), including 35% females; 44% of patients received HDV. Hospital mortality was higher among patients receiving HDV (42% vs. 16%, unadjusted OR 3.87, 95% CI 3.16–4.75, P < .01). On multivariable analysis in HDV patients, hospital mortality increased with rising peak NEE (adjusted OR 1.02 per 0.01 mcg/kg/min, 95% CI 1.01–1.02, P < .01) and the use of NE was associated with lower hospital mortality (adjusted OR 0.46, 95% CI 0.31–0.72 P < .01). After adjustment for illness severity, peak NEE and norepinephrine use were not associated with mortality among patients who did not require HDV. Conclusions: Mortality is high among CICU patients requiring HDV, and rises with increasing vasopressor requirements. Use of NE was associated with lower mortality among patients requiring HDV, but not among those without HDV, implying that patients with more severe shock may benefit from preferential use of NE.Keywords
This publication has 33 references indexed in Scilit:
- Therapeutic Strategies for High-Dose Vasopressor-Dependent ShockCritical Care Research and Practice, 2013
- History of the Rochester Epidemiology Project: Half a Century of Medical Records Linkage in a US PopulationMayo Clinic Proceedings, 2012
- Derivation and Validation of Automated Electronic Search Strategies to Extract Charlson Comorbidities From Electronic Medical RecordsMayo Clinic Proceedings, 2012
- Mapping physicians' admission diagnoses to structured concepts towards fully automatic calculation of acute physiology and chronic health evaluation scoreBMJ Open, 2011
- Informatics Infrastructure for Syndrome Surveillance, Decision Support, Reporting, and Modeling of Critical IllnessMayo Clinic Proceedings, 2010
- Comparison of Dopamine and Norepinephrine in the Treatment of ShockThe New England Journal of Medicine, 2010
- Inotropes and VasopressorsCirculation, 2008
- Early increases in microcirculatory perfusion during protocol-directed resuscitation are associated with reduced multi-organ failure at 24 h in patients with sepsisIntensive Care Medicine, 2008
- Does dopamine administration in shock influence outcome? Results of the Sepsis Occurrence in Acutely Ill Patients (SOAP) Study*Critical Care Medicine, 2006
- Arginine vasopressin in 316 patients with advanced vasodilatory shock*Critical Care Medicine, 2005